World Health Organization (2022) WHO COVID-19 dashboard. https://covid19.who.int/
Shiravi AA, Ardekani A, Sheikhbahaei E, Heshmat-Ghahdarijani K (2021) Cardiovascular complications of SARS-CoV-2 vaccines: an overview. Cardiol Therapy. https://doi.org/10.1007/s40119-021-00248-0
World Health Association. COVID-19 vaccines advice. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice Accessed 18 Dec 2021.
Kyriakidis NC, López-Cortés A, González EV, Grimaldos AB, Prado EO (2021) SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates. NPJ Vaccines 6(1):28–28. https://doi.org/10.1038/s41541-021-00292-w
Olivieri B, Betterle C, Zanoni G (2021) Vaccinations and autoimmune diseases. Vaccines 9(8):815. https://doi.org/10.3390/vaccines9080815
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C et al (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383(27):2603–2615. https://doi.org/10.1056/NEJMoa2034577
Lim HX, Arip M, Yahaya AAA-F, Jazayeri SD, Poppema S, Poh CL (2021) Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials. Front Biosci 26(11):1286–1304. https://doi.org/10.52586/5024
Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, Okosieme OE (2018) Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol 14(5):301–316. https://doi.org/10.1038/nrendo.2018.18
Jafarzadeh A, Poorgholami M, Izadi N, Nemati M, Rezayati M (2010) Immunological and hematological changes in patients with hyperthyroidism or hypothyroidism. Clin Invest Med 33(5):E271–E279. https://doi.org/10.25011/cim.v33i5.14352
Bargiel P, Szczuko M, Stachowska L, Prowans P, Czapla N, Markowska M, Petriczko J, Kledzik J, Jędrzejczyk-Kledzik A, Palma J et al (2021) Microbiome metabolites and thyroid dysfunction. J Clin Med 10(16):3609. https://doi.org/10.3390/jcm10163609
Aemaz Ur Rehman M, Farooq H, Ali MM, Ebaad Ur Rehman M, Dar QA, Hussain A (2021) The association of subacute thyroiditis with COVID-19: a systematic review. SN Compr Clin Med. https://doi.org/10.1007/s42399-021-00912-5
Stasiak M, Lewiński A (2021) New aspects in the pathogenesis and management of subacute thyroiditis. Rev Endocr Metab Disord 22(4):1027–1039. https://doi.org/10.1007/s11154-021-09648-y
Ohsako N, Tamai H, Sudo T, Mukuta T, Tanaka H, Kuma K, Kimura A, Sasazuki T (1995) Clinical characteristics of subacute thyroiditis classified according to human leukocyte antigen typing. J Clin Endocrinol Metab 80(12):3653–3656. https://doi.org/10.1210/jcem.80.12.8530615
Stasiak M, Tymoniuk B, Michalak R, Stasiak B, Kowalski ML, Lewiński A (2020) Subacute thyroiditis is associated with HLA-B*18:01, -DRB1*01 and -C*04:01-the significance of the new molecular background. J Clin Med 9(2):534. https://doi.org/10.3390/jcm9020534
Fatourechi V, Aniszewski JP, Fatourechi GZ, Atkinson EJ, Jacobsen SJ (2003) Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J Clin Endocrinol Metab 88(5):2100–2105. https://doi.org/10.1210/jc.2002-021799
Al-Tikrity MA, Magdi M, Abou Samra AB, Elzouki AY (2020) Subacute thyroiditis: an unusual presentation of fever of unknown origin following upper respiratory tract infection. Am J Case Rep 21:e920515. https://doi.org/10.12659/ajcr.920515
Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P (2020) Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord 22(4):803–815. https://doi.org/10.1007/s11154-020-09615-z
Pearce EN, Farwell AP, Braverman LE (2003) Thyroiditis. N Engl J Med 348(26):2646–2655. https://doi.org/10.1056/NEJMra021194
Patel KR, Cunnane ME, Deschler DG (2021) SARS-CoV-2 vaccine-induced subacute thyroiditis. Am J Otolaryngol 43(1):103211. https://doi.org/10.1016/j.amjoto.2021.103211
Görges J, Ulrich J, Keck C, Müller-Wieland D, Diederich S, Janssen OE (2020) Long-term outcome of subacute thyroiditis. Exp Clin Endocrinol Diabetes 128(11):703–708. https://doi.org/10.1055/a-0998-8035
Samuels MH (2012) Subacute, silent, and postpartum thyroiditis. Med Clin North Am 96(2):223–233. https://doi.org/10.1016/j.mcna.2012.01.003
Li JH, Daniels GH, Barbesino G (2021) Painful subacute thyroiditis is commonly misdiagnosed as suspicious thyroid nodular disease. Mayo Clinic Proc Innov Qual Outcomes 5(2):330–337. https://doi.org/10.1016/j.mayocpiqo.2020.12.007
Cappelli C, Pirola I, Gandossi E, Formenti AM, Agosti B, Castellano M (2014) Ultrasound findings of subacute thyroiditis: a single institution retrospective review. Acta Radiol 55(4):429–433. https://doi.org/10.1177/0284185113498721
Vural Ç, Paksoy N, Gök ND, Yazal K (2015) Subacute granulomatous (De Quervain’s) thyroiditis: fine-needle aspiration cytology and ultrasonographic characteristics of 21 cases. Cytojournal 12:9. https://doi.org/10.4103/1742-6413.157479
Bornemann C, Woyk K, Bouter C (2021) Case report: two cases of subacute thyroiditis following SARS-CoV-2 vaccination. Front Med 8:737142. https://doi.org/10.3389/fmed.2021.737142
Plaza-Enriquez L, Khatiwada P, Sanchez-Valenzuela M, Sikha A (2021) A case report of subacute thyroiditis following mRNA COVID-19 vaccine. Case Rep Endocrinol 2021:8952048. https://doi.org/10.1155/2021/8952048
Siolos A, Gartzonika K, Tigas S (2021) Thyroiditis following vaccination against COVID-19: report of two cases and review of the literature. Metabol Open 12:100136. https://doi.org/10.1016/j.metop.2021.100136
Pujol A, Gómez LA, Gallegos C, Nicolau J, Sanchís P, González-Freire M, López-González ÁA, Dotres K, Masmiquel L (2021) Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves’ disease to silent thyroiditis. J Endocrinol Invest. https://doi.org/10.1007/s40618-021-01707-0
Chatzi S, Karampela A, Spiliopoulou C, Boutzios G (2021) Subacute thyroiditis after SARS-CoV-2 vaccination: a report of two sisters and summary of the literature. Hormones 21(1):177–179. https://doi.org/10.1007/s42000-021-00332-z
Şahin Tekin M, Şaylısoy S, Yorulmaz G (2021) Subacute thyroiditis following COVID-19 vaccination in a 67-year-old male patient: a case report. Hum Vaccin Immunother 17(11):4090–4092. https://doi.org/10.1080/21645515.2021.1947102
Oyibo SO (2021) Subacute thyroiditis after receiving the adenovirus-vectored vaccine for coronavirus disease (COVID-19). Cureus 13:e16045. https://doi.org/10.7759/cureus.16045
İremli BG, Şendur SN, Ünlütürk U (2021) Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: postvaccination ASIA Syndrome. J Clin Endocrinol Metab 106(9):2600–2605. https://doi.org/10.1210/clinem/dgab373
Franquemont S, Galvez J (2021) Subacute thyroiditis after mRNA vaccine for Covid-19. J Endocr Soc 5:A956–A957. https://doi.org/10.1210/jendso/bvab048.1954
Jeeyavudeen MS, Patrick AW, Gibb FW, Dover AR (2021) COVID-19 vaccine-associated subacute thyroiditis: an unusual suspect for de Quervain’s thyroiditis. BMJ Case Rep 14(11):e246425. https://doi.org/10.1136/bcr-2021-246425
Kyriacou A, Ioakim S, Syed AA (2021) COVID-19 vaccination and a severe pain in the neck. Eur J Intern Med 94:95–96. https://doi.org/10.1016/j.ejim.2021.10.008
Saygılı ES, Karakilic E (2021) Subacute thyroiditis after inactive SARS-CoV-2 vaccine. BMJ Case Reports 14:e244711. https://doi.org/10.1136/bcr-2021-244711
Soltanpoor P, Norouzi G (2021) Subacute thyroiditis following COVID-19 vaccination. Clin Case Rep 9:e04812. https://doi.org/10.1002/ccr3.4812
Schimmel J, Alba EL, Chen A, Russell M, Srinath R (2021) Letter to the editor: thyroiditis and thyrotoxicosis after the SARS-CoV-2 mRNA vaccine. Thyroid 31(9):1440. https://doi.org/10.1089/thy.2021.0184
Ratnayake GM, Dworakowska D, Grossman AB (2021) Can COVID-19 immunisation cause subacute thyroiditis? Clin Endocrinol. https://doi.org/10.1111/cen.14555.10.1111/cen.14555
Lee KA, Kim YJ, Jin HY (2021) Thyrotoxicosis after COVID-19 vaccination: seven case reports and a literature review. Endocrine 74(3):470–472. https://doi.org/10.1007/s12020-021-02898-5
Khan F, Brassill MJ (2021) Subacute thyroiditis post-Pfizer-BioNTech mRNA vaccination for COVID-19. Endocrinol Diabetes Metab Case Rep 2021:21–0142. https://doi.org/10.1530/edm-21-0142
Leber HM, Sant’Ana L, Konichi da Silva NR, Raio MC, Mazzeo T, Endo CM, Nascimento H, de Souza CE (2021) Acute thyroiditis and bilateral optic neuritis following SARS-CoV-2 vaccination with CoronaVac: a case report. Ocul Immunol Inflamm 29(6):1200–1206. https://doi.org/10.1080/09273948.2021.1961815
Sözen M, Topaloğlu Ö, Çetinarslan B, Selek A, Cantürk Z, Gezer E, Köksalan D, Bayraktaroğlu T (2021) COVID-19 mRNA vaccine may trigger subacute thyroiditis. Hum Vaccin Immunother 17(12):5120–5125. https://doi.org/10.1080/21645515.2021.2013083
Pandya M, Thota G, Wang X, Luo H (2021) Thyroiditis after coronavirus disease 2019 (COVID-19) mRNA vaccine: a case series. AACE Clin Case Rep. https://doi.org/10.1016/j.aace.2021.12.002
Pla Peris B, Merchante Alfaro AÁ, Maravall Royo FJ, Abellán Galiana P, Pérez Naranjo S, González Boillos M (2022) Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion. J Endocrinol Invest. https://doi.org/10.1007/s40618-022-01739-0
Bostan H, Unsal IO, Kizilgul M, Gul U, Sencar ME, Ucan B, Cakal E (2022) Two cases of subacute thyroiditis after different types of SARS-CoV-2 vaccination. Arch Endocrinol Metab. https://doi.org/10.20945/2359-3997000000430
Jhon M, Lee SH, Oh TH, Kang HC (2022) Subacute thyroiditis after receiving the mRNA COVID-19 vaccine (Moderna): the first case report and literature review in Korea. J Korean Med Sci 37:e39. https://doi.org/10.3346/jkms.2022.37.e39
Vasileiou V, Paschou SA, Tzamali X, Mitropoulou M, Kanouta F, Psaltopoulou T, Kassi GN (2022) Recurring subacute thyroiditis after SARS-CoV-2 mRNA vaccine: A case report. Case Rep Womens Health 33:e00378. https://doi.org/10.1016/j.crwh.2021.e00378
Yorulmaz G, Sahin Tekin M (2022) SARS-CoV-2 vaccıne-assocıated subacute thyroıdıtıs. J Endocrinol Invest. https://doi.org/10.1007/s40618-022-01767-w
Davies TF, Andersen S, Latif R, Nagayama Y, Barbesino G, Brito M, Eckstein AK, Stagnaro-Green A, Kahaly GJ (2020) Graves’ disease. Nat Rev Dis Primers 6:52. https://doi.org/10.1038/s41572-020-0184-y
Antonelli A, Ferrari SM, Ragusa F, Elia G, Paparo SR, Ruffilli I, Patrizio A, Giusti C, Gonnella D, Cristaudo A et al (2020) Graves’ disease: epidemiology, genetic and environmental risk factors and viruses. Best Pract Res Clin Endocrinol Metab 34(1):101387. https://doi.org/10.1016/j.beem.2020.101387
Fröhlich E, Wahl R (2017) Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front Immunol 8:521–521. https://doi.org/10.3389/fimmu.2017.00521
Murugan AK, Alzahrani AS (2021) SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves’ disease. Endocrine 73(2):243–254. https://doi.org/10.1007/s12020-021-02770-6
Mehraji Z, Farazmand A, Esteghamati A, Noshad S, Sadr M, Amirzargar S, Yekaninejad MS, Amirzargar A (2017) Association of human leukocyte antigens class I and II with Graves’ Disease in Iranian population. Iran J Immunol 14(3):223–230
Zettinig G, Krebs M (2021) Two further cases of Graves’ disease following SARS-Cov-2 vaccination. J Endocrinol Invest 45(1):227–228. https://doi.org/10.1007/s40618-021-01650-0
Raven LM, McCormack AI, Greenfield JR (2021) Letter to the editor from Raven: three cases of Subacute Thyroiditis following SARS-CoV-2 vaccine. J Clin Endocrinol Metab 106(9):2600–2605. https://doi.org/10.1210/clinem/dgab822
Vera-Lastra O, Ordinola Navarro A, Cruz Domiguez MP, Medina G, Sánchez Valadez TI, Jara LJ (2021) Two cases of Graves’ Disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants. Thyroid 31(9):1436–1439. https://doi.org/10.1089/thy.2021.0142
Lui DTW, Lee KK, Lee CH, Lee ACH, Hung IFN, Tan KCB (2021) Development of Graves’ Disease after SARS-CoV-2 mRNA vaccination: a case report and literature review. Front Public Health 9:778964. https://doi.org/10.3389/fpubh.2021.778964
Weintraub MA, Ameer B, Sinha Gregory N (2021) Graves Disease following the SARS-CoV-2 vaccine: case series. J Investig Med High Impact Case Rep 9:23247096211063356. https://doi.org/10.1177/23247096211063356
Sriphrapradang C, Shantavasinkul PC (2021) Graves’ disease following SARS-CoV-2 vaccination. Endocrine 74(3):473–474. https://doi.org/10.1007/s12020-021-02902-y
Patrizio A, Ferrari SM, Antonelli A, Fallahi P (2021) A case of Graves’ disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination. J Autoimmun 125:102738. https://doi.org/10.1016/j.jaut.2021.102738
Pierman G, Delgrange E, Jonas C (2021) Recurrence of Graves’ Disease (a Th1-type Cytokine Disease) following SARS-CoV-2 mRNA vaccine administration: a simple coincidence? Eur J Case Rep Intern Med 8(9):002807–002807. https://doi.org/10.12890/2021_002807
Goblirsch TJ, Paulson AE, Tashko G, Mekonnen AJ (2021) Graves’ disease following administration of second dose of SARS-CoV-2 vaccine. BMJ Case Rep 14(12):e246432. https://doi.org/10.1136/bcr-2021-246432
Sakiyama R (1986) Silent thyroiditis. J Fam Pract 23:367–369
McAlinden C (2014) An overview of thyroid eye disease. Eye Vis 1:9–9. https://doi.org/10.1186/s40662-014-0009-8
Lazarus JH (2012) Epidemiology of Graves’ orbitopathy (GO) and relationship with thyroid disease. Best Pract Res Clin Endocrinol Metab 26(3):273–279. https://doi.org/10.1016/j.beem.2011.10.005
Łacheta D, Miśkiewicz P, Głuszko A, Nowicka G, Struga M, Kantor I, Poślednik KB, Mirza S, Szczepański MJ (2019) Immunological aspects of Graves’ ophthalmopathy. Biomed Res Int 2019:7453260–7453260. https://doi.org/10.1155/2019/7453260
Rubinstein TJ (2021) Thyroid eye disease following COVID-19 vaccine in a patient with a history Graves’ Disease: a case report. Ophthalmic Plast Reconstr Surg 37(6):e221–e223. https://doi.org/10.1097/iop.0000000000002059
Capezzone M, Tosti-Balducci M, Morabito EM, Caldarelli GP, Sagnella A, Cantara S, Alessandri M, Castagna MG (2022) Silent thyroiditis following vaccination against COVID-19: report of two cases. J Endocrinol Invest. https://doi.org/10.1007/s40618-021-01725-y
Nakaizumi N, Fukata S, Akamizu T (2022) Painless thyroiditis following mRNA vaccination for COVID-19. Hormones. https://doi.org/10.1007/s42000-021-00346-7
Giusti M, Maio A (2021) Acute thyroid swelling with severe hypothyroid myxoedema after COVID-19 vaccination. Clin Case Rep 9:e05217. https://doi.org/10.1002/ccr3.5217
Hernán Martinez J, Corder E, Uzcategui M, Garcia M, Sostre S, Garcia A (2011) Subacute thyroiditis and dyserythropoesis after influenza vaccination suggesting immune dysregulation. Bol Asoc Med P R 103(2):48–52
Girgis CM, Russo RR, Benson K (2010) Subacute thyroiditis following the H1N1 vaccine. J Endocrinol Invest 33(7):506. https://doi.org/10.1007/bf03346633
Altay FA, Güz G, Altay M (2016) Subacute thyroiditis following seasonal influenza vaccination. Hum Vaccin Immunother 12(4):1033–1034. https://doi.org/10.1080/21645515.2015.1117716
Passah A, Arora S, Damle NA, Reddy KS, Khandelwal D, Aggarwal S (2018) Occurrence of Subacute Thyroiditis following influenza vaccination. Indian J Endocrinol Metab 22(5):713–714. https://doi.org/10.4103/ijem.IJEM_237_18
Pellegrino P, Perrone V, Pozzi M, Carnovale C, Perrotta C, Clementi E, Radice S (2015) The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems. Immunol Res 61(1–2):90–96. https://doi.org/10.1007/s12026-014-8567-3
Xie Q, Mu XY, Li SQ (2021) Subacute thyroiditis following HPV vaccination: a case report. Sichuan Da Xue Xue Bao Yi Xue Ban 52(6):1047–1048. https://doi.org/10.12182/20211160506
Toft J, Larsen S, Toft H (1998) Subacute thyroiditis after hepatitis B vaccination. Endocr J 45(1):135
Bragazzi NL, Hejly A, Watad A, Adawi M, Amital H, Shoenfeld Y (2020) ASIA syndrome and endocrine autoimmune disorders. Best Pract Res Clin Endocrinol Metab 34(1):101412. https://doi.org/10.1016/j.beem.2020.101412
Murugan AK, Alzahrani AS (2021) SARS-CoV-2: emerging role in the pathogenesis of various thyroid diseases. J Inflamm Res 14:6191–6221. https://doi.org/10.2147/jir.s332705
Giovanella L, Ruggeri RM, Ovčariček PP, Campenni A, Treglia G, Deandreis D (2021) Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review. Clin Transl Imaging. https://doi.org/10.1007/s40336-021-00419-y
Vojdani A, Vojdani E, Kharrazian D (2020) Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front Immunol 11:617089. https://doi.org/10.3389/fimmu.2020.617089
Vojdani A, Kharrazian D (2020) Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol 217:108480. https://doi.org/10.1016/j.clim.2020.108480
Jadali Z (2020) COVID- 19 and thyroid infection: learning the lessons of the past. Acta Endocrinol 16(3):375–376. https://doi.org/10.4183/aeb.2020.375
Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA, Field JA, Steere AC, Huber BT (1998) Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 281(5377):703–706. https://doi.org/10.1126/science.281.5377.703
Vadalà M, Poddighe D, Laurino C, Palmieri B (2017) Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon? EPMA J 8(3):295–311. https://doi.org/10.1007/s13167-017-0101-y
Chen RT, Pless R, Destefano F (2001) Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun 16(3):309–318. https://doi.org/10.1006/jaut.2000.0491
Yazdanpanah N, Rezaei N (2022) Autoimmune complications of COVID-19. J Med Virol 94(1):54–62. https://doi.org/10.1002/jmv.27292
Safdari V, Alijani E, Nemati M, Jafarzadeh A (2017) Imbalances in T cell-related transcription factors among patients with Hashimoto’s Thyroiditis. Sultan Qaboos Univ Med J 17(2):e174–e180. https://doi.org/10.18295/squmj.2016.17.02.007
Janyga S, Marek B, Kajdaniuk D, Ogrodowczyk-Bobik M, Urbanek A, Bułdak Ł (2021) CD4+ cells in autoimmune thyroid disease. Endokrynol Pol 72(5):572–583. https://doi.org/10.5603/EP.a2021.0076
Teijaro JR, Farber DL (2021) COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol 21(4):195–197. https://doi.org/10.1038/s41577-021-00526-x
Jafarzadeh A, Chauhan P, Saha B, Jafarzadeh S, Nemati M (2020) Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions. Life Sci 257:118102. https://doi.org/10.1016/j.lfs.2020.118102
Zhang C, Maruggi G, Shan H, Li J (2019) Advances in mRNA vaccines for infectious diseases. Front Immunol 10:594. https://doi.org/10.3389/fimmu.2019.00594
Singh RP, Bischoff DS (2021) Sex hormones and gender influence the expression of markers of regulatory T cells in SLE patients. Front Immunol 12:619268. https://doi.org/10.3389/fimmu.2021.619268
Tu Y, Fan G, Zeng T, Cai X, Kong W (2018) Association of TNF-α promoter polymorphism and Graves’ disease: an updated systematic review and meta-analysis. Biosci Rep 38:BSR20180143. https://doi.org/10.1042/BSR20180143
Davarpanah E, Jafarzadeh A, Nemati M, Bassagh A, Abasi MH, Khosravimashizi A, Kazemipoor N, Ghazizadeh M, Mirzaee M (2020) Circulating concentration of interleukin-37 in Helicobacter pylori-infected patients with peptic ulcer: Its association with IL-37 related gene polymorphisms and bacterial virulence factor CagA. Cytokine 126:154928. https://doi.org/10.1016/j.cyto.2019.154928
Ritchie H, Mathieu E, Rodés-Guirao L, Appel C, Giattino C, Ortiz-Ospina E, Hasell J, Macdonald B, Beltekian D, Roser M (2020) "Coronavirus Pandemic (COVID-19)". Published online at OurWorldInData.org. 'https://ourworldindata.org/coronavirus'.